{
    "2021-12-03": [
        [
            {
                "time": "2023-10-16",
                "original_text": "AbbVie Provides Update on RINVOQ® (upadacitinib) for the Treatment of Rheumatoid Arthritis in the U.S.",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "RINVOQ",
                        "upadacitinib",
                        "Rheumatoid Arthritis",
                        "U.S."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Warren Buffett’s Picks: 10 Stocks to Watch",
                "features": {
                    "keywords": [
                        "Warren Buffett",
                        "Picks",
                        "Stocks",
                        "Watch"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "10 Dividend Stocks That Have Doubled Their Payouts",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Stocks",
                        "Doubled",
                        "Payouts"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Pharma Stock Roundup: FDA Panel Vote for MRK COVID Pill, JNJ Omicron Jab Plan",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "FDA",
                        "Panel",
                        "Vote",
                        "MRK",
                        "COVID",
                        "Pill",
                        "JNJ",
                        "Omicron",
                        "Jab",
                        "Plan"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}